HC9 Ventures Invests in Optura to Accelerate “Return on AI Investment” (ROAI)
At Optura, our mission has always been clear: end AI paralysis in healthcare. Today, that mission is gaining even more momentum.
We’re proud to share that HC9 Ventures has made a strategic investment in Optura, their 10th Fund I investment and their first in what’s now being called the ROAI (“Return on AI Investment”) category.
This partnership reinforces what we’ve believed from the start: healthcare doesn’t need more AI experiments. It needs measurable results.
Where Healthcare Finds Its AI North Star
Healthcare organizations are leaving millions on the table every year because fragmented AI initiatives can’t scale, connect, or demonstrate ROI. Optura changes that.
Our AI orchestration platform unifies disconnected pilots and point solutions into one cohesive, enterprise-wide program, giving healthcare leaders full visibility, accountability, and confidence in their AI investments.
“Optura is the essential AI backbone for healthcare executives, achieving millions of dollars in cost savings for a typical healthcare enterprise,” said Richard Lungen, General Partner and Co-Founder of HC9 Ventures.
“We are honored and excited to be working alongside respected innovators who have driven billions in enterprise value during their collective careers at the intersection of technology and healthcare.”
Powering Progress: The Road Ahead for Optura
This investment from HC9 will enable us to:
Expand our library of healthcare-specific AI agents, solving real problems in claims, utilization, prior authorization, and risk stratification.
Scale our implementation team to meet growing demand from healthcare organizations and partners.
Accelerate product development, including features like autonomous orchestration and real-time simulation tools.
As Optura CEO, Andy Fanning shared, “Mid-sized and large health plans, as well as larger providers, are all scrambling to integrate AI offerings. However, the lack of clarity around financial ROI creates uncertainty for decision-makers…As a purpose-built AI orchestration platform, rather than a point-solution, Optura brings scale and clarity to healthcare leaders, ultimately driving tangible ROAI.”
The ROAI Era Has Arrived
HC9 Ventures’ investment follows our $6.5M seed funding announced earlier this year from Susa Ventures and Matrix Partners. Together, these partnerships are propelling a new movement in healthcare, one grounded in measurable ROAI.
